Orlando, FL (openPR) 7 October 2010

Medyssey Co., Ltd. (Medyssey Spine), now a record 112 percent increase in sales in 2010, announced in Q3 compared to Q3 2009. Medyssey Spine, private, reported that sales of the year to date by 73 percent compared to 2009, the company is on track to reach his seventh year as a result of growth in market share over the spine market.

The announcement was made at the North American Spine Society (NASS), which the 25th Annual Meeting in Orlando, FL has made from October 5 to 9 at the Orange County Convention Center in Orlando. Medysseyâ? S booth at NASS (2051).

Company officials attributed the increase to the completion of regulatory approvals, several other key distributors in emerging markets, and the start of the U.S. distributor for his initiative.

commented on the financial and operating results, Joseph Jin Spinea Medyssey? s vice president said, â? Our growth is a testament to the strength of our global presence in the growing dissemination and implementation strategies in markets such as Brazil, China and the United States? He added: â? We are now in a strong position on a number of measures, including cash flow rose significantly reduced debt and robust products in the> pipeline.â ????

United States, Mr. Jin said, â? An aggressive release cycle, with the approval of the products that continue to the FDA, our U.S. headquarters moved to Chicago, IL submitted and is expected to logistics efficiency for our operations in Q1 2011th We remain very optimistic about the continued growth and achieving our forecasts for 2011, we officially launched our portfolio and new product extensions thoracolumbar> NASS.â ????

Medyssey Spine recently crossed a milestone of 2,200 cases of its instruments WaveFlex rear rigid system of Rod, a dynamic stabilization device with an indication of an addition to fusion in the Asia-Pacific and the EU.

â? Surgeon response was overwhelmingly positive, â? Said Mr. Jin. â? Important factors in the clinical differentiation of our technology are in resonance with surgeons.â? He added: â? Our portfolio of evidence of a philosophy of developing safe and effective, the added value of spinal implants are under the mantra of the p> and designed simple reproducible.â ???? About

spine Medyssey

Drawings Medyssey

develops, manufactures and markets products for the surgical treatment of spinal disorders through new tools and solutions, the rate of fusion OrthoBiologics to improve conservation of mobility, and the clinical results. Please visit www.medyssey.com for information.

CONTACT:

Joseph Jin


Vice President
Spine Medyssey

312.852.2700

joseph.jin (at) medyssey (dot) com

Http: / / www.medyssey.com

Todd E. Appleman


President

The Appleman Group

323.850.7664
tappleman
(at) tag-pr (dot) com

# # #

clear = “all”
Residential treatment centers for eating disorders